NCT01391559View on ClinicalTrials.gov

Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

arformoterol

15 mcg administered via nebulizer

DRUG

salmeterol

50 mcg delivered vis Diskus

Trial Locations (1)

03756-0001

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01391559 - Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter